Literature DB >> 17343833

Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.

Michael Wallisch1, Cole S Nelson, Julia M Mulvaney, Heather S Hernandez, Sue Ann Smith, George D Olsen.   

Abstract

Chronic opioid treatment leads to agonist-specific effects at the mu opioid receptor. The molecular mechanisms resulting from chronic opioid exposure include desensitization, internalization and down-regulation of membrane-bound mu opioid receptors (MOP). The purpose of this study was to compare the cellular regulation of guinea pig, human and rat MOP expressed in Chinese hamster ovary (CHO) cells, following exposure to two clinically important opioids, morphine and methadone. MOP expressing CHO cells were treated in culture with methadone or morphine for up to 48 h. Radioligand diprenorphine and [D-AIa(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO)-stimulated GTP gamma S binding assays were carried out using paired control and opioid-exposed CHO cells. Methadone induced downregulation of the mu opioid receptor, while morphine induced desensitization of the receptor for all three species. Furthermore, morphine predominantly decreased the potency of DAMGO to stimulate GTP gamma S binding, whereas methadone primarily reduced its efficacy. Changes in DAMGO potency and efficacy differed among species and depended on the opioid used to treat the cells. Our results showed similarities between guinea pig and human MOP for morphine-induced desensitization, but identified differences between the two for methadone-induced desensitization. In contrast, human and rat MOP differed in response to morphine treatment, but were not distinct in their response to methadone treatment. The guinea pig is an excellent and established animal model to study opioid effects, but its molecular opioid pharmacology has not been investigated thus far. These results can assist in understanding species differences in the effects of opioid ligands activating the mu opioid receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17343833      PMCID: PMC1950480          DOI: 10.1016/j.bcp.2007.02.001

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  35 in total

1.  Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.

Authors:  Jin Li; Jian-Guo Li; Chongguang Chen; Fengqin Zhang; Lee-Yuan Liu-Chen
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

2.  The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells.

Authors:  I Onoprishvili; M L Andria; F S Vilim; J M Hiller; E J Simon
Journal:  Brain Res Mol Brain Res       Date:  1999-11-10

3.  Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.

Authors:  R E Gray; M W Munks; R R Haynes; G D Olsen
Journal:  Brain Res Bull       Date:  2001-03-15       Impact factor: 4.077

4.  Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors.

Authors:  Stephanie L Borgland; Mark Connor; Peregrine B Osborne; John B Furness; MacDonald J Christie
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

5.  Distinct domains of the mu-opioid receptor control uncoupling and internalization.

Authors:  Jeremy Celver; Mei Xu; Wenzhen Jin; Janet Lowe; Charles Chavkin
Journal:  Mol Pharmacol       Date:  2004-03       Impact factor: 4.436

6.  Guinea pig mu opioid receptor: brainstem expression in the morphine-exposed neonate.

Authors:  Sue Ann Smith; James T Stupfel; Nasreen A Ilias; George D Olsen
Journal:  Neurotoxicol Teratol       Date:  2004 Jan-Feb       Impact factor: 3.763

7.  mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization.

Authors:  Veronica A Alvarez; Seksiri Arttamangkul; Vu Dang; Abdallah Salem; Jennifer L Whistler; Mark Von Zastrow; David K Grandy; John T Williams
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

8.  (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.

Authors:  Fengqin Zhang; Jin Li; Jian-Guo Li; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

9.  Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.

Authors:  Christopher P Bailey; Daniel Couch; Elizabeth Johnson; Katie Griffiths; Eamonn Kelly; Graeme Henderson
Journal:  J Neurosci       Date:  2003-11-19       Impact factor: 6.167

10.  Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.

Authors:  J B Wang; P S Johnson; A M Persico; A L Hawkins; C A Griffin; G R Uhl
Journal:  FEBS Lett       Date:  1994-01-31       Impact factor: 4.124

View more
  4 in total

1.  Activation of µ-opioid receptors and block of Kir3 potassium channels and NMDA receptor conductance by L- and D-methadone in rat locus coeruleus.

Authors:  Aya Matsui; John T Williams
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Respiratory effects of chronic in utero methadone or morphine exposure in the neonatal guinea pig.

Authors:  Rosemary T Nettleton; Michael Wallisch; George D Olsen
Journal:  Neurotoxicol Teratol       Date:  2008-03-21       Impact factor: 3.763

3.  S-Methadone augments R-methadone induced respiratory depression in the neonatal guinea pig.

Authors:  Daniel A N Silverman; Rosemary T Nettleton; Katherine B Spencer; Michael Wallisch; George D Olsen
Journal:  Respir Physiol Neurobiol       Date:  2009-09-08       Impact factor: 1.931

4.  Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.

Authors:  Luca Posa; Alison Accarie; Florence Noble; Nicolas Marie
Journal:  Int J Neuropsychopharmacol       Date:  2016-06-29       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.